Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's what I was thinking too "wipe it out before it mutates too much"
Having an 85 % chance of not requiring a hospital visit, easy storage and ability to produce a billion shots quickly will save America. FDA we need you. We can wipe it out before it mutates. :)
The article is great news.
Read the entire article and you will see that it is still a great vaccine and will continue to save lives and spare many hospitalization.
What every everyone does;
Don't freaking panic sell this stock.
$JNJ
The Johnson & Johnson covid 19 vaccine (developped in Beerse Belgium) is the first one shot which will release his phase III trial results.
Johnson & Johnson will release Covid-19 Vaccine Trial Results Today
I Hope you're right
JNJ is going to be the big winner in the vaccine category because of the one shot and no refrigerating necessary. JMO
Sen Rob Portman pumping up JNJ stock on CNBC. Wonder how much stock his close network bought before hand?
BREAKING NEWS: $JNJ Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development
Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase ...
In case you are interested JNJ - Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development
News; $JNJ Why You Shouldn't Ignore Johnson & Johnson
The year 2020 has been full of surprises. Growth stocks, which are usually the first to get battered during economic downturns, have performed exceptionally well, while many stable and mature companies have been poor performers. Historically, Johnson & Johnson (NYSE: JNJ) ha...
In case you are interested JNJ - Why You Shouldn't Ignore Johnson & Johnson
$jnj We cannot rely on magical thinking: Herd immunity is not a plan
https://statnews.com/2020/10/16/we-cannot-rely-on-magical-thinking-herd-immunity-is-not-a-plan/
$JNJ Covid-19: The fatal attraction of herd immunity https://www.bmj.com/content/370/bmj.m3714/rr-0
It’s back on baby!
Another vaccine trial on pause. This time it’s J&J’s which is using a non-replicating adenovirus platform like the AstraZeneca vaccine that is currently halted in the US.
https://www.nytimes.com/live/2020/10/13/world/coronavirus-covid#johnson-johnson-pauses-its-coronavirus-vaccine-trial-because-of-a-volunteers-unexplained-illness
News; $JNJ 2 Healthcare Stocks That Are Perfect for Retirement
Whether you're planning for retirement or have already retired, the one thing you'll probably want from your investments is consistency. What 2020 has shown investors is just how volatile the stock market can be; stock prices can rise or fall without warning. That's why it's important to ha...
Read the whole news JNJ - 2 Healthcare Stocks That Are Perfect for Retirement
BREAKING NEWS: $JNJ Better Coronavirus Stock: Johnson & Johnson vs. Novavax
Two very different drugmakers have recently joined the elite group of companies with coronavirus vaccines in late-stage testing. Johnson & Johnson (NYSE: JNJ) initiated a global phase 3 clinical study of JNJ-78436735 (also known as Ad26.COV2.S) on Sept. 23. Novavax (NA...
In case you are interested JNJ - Better Coronavirus Stock: Johnson & Johnson vs. Novavax
I thought it was very informative!!
Hi all,
Please see our fundamental analysis of JNJ against some of its main competitors.
If any suggestions for improvement let us know.
Thx.
May be a good buy ?
Just started phase 3 today September 25
Vaccine needs just one shot
Vaccine can be kept at refrigerator temperature
I've been asking this question all week. Which one of these would be the best to buy?
NEWS: $JNJ 3 Best Coronavirus Vaccine Stocks to Buy Right Now
The coronavirus vaccines are coming -- or at least the odds are looking better every day that they are. Investors who want to potentially benefit from the launches of coronavirus vaccines have plenty of options from which to choose. However, the number of low-risk leaders in the race are few. H...
In case you are interested JNJ - 3 Best Coronavirus Vaccine Stocks to Buy Right Now
They should buy!! UEEC!!!!
Why J&J is delighted today in the search of a vaccine:
https://pennystocks.news/why-jj-is-delighted-about-the-syrian-golden-hamsters-in-the-search-of-a-vaccine-jnj/?preview=true&_thumbnail_id=76758
UBS has words of praise for $JNJ
https://pennystocks.news/how-the-covid-19-vaccine-mania-is-most-profitable-for-investors-jnj/
$JNJ Thursday, The Wall Street Journal reported that Johnson & Johnson (JNJ) plans a 60,000 person trial of its Covid-19 vaccine by late next month.
Mandatory vaccinations are Unconstitutional!
Supreme Court risks being exposed as being partial to a self dealing government.
$JNJ Johnson and Johnson (JNJ)
147.51 ? -0.52 (-0.35%)
Volume: 3,190,400 @08/11/20 12:44:44 PM EDT
Bid Ask Day's Range
- - 147.41 - 149.23
JNJ Detailed Quote
US secures 100M doses of JNJ’s COVID-19 vaccine with >$1B grant:
https://www.prnewswire.com/news-releases/johnson--johnson-announces-agreement-with-us-government-for-100-million-doses-of-investigational-covid-19-vaccine-301106593.html
Janssen approves Aleafia Health to Administer Antidepressant SPRAVATO®
https://www.globenewswire.com/news-release/2020/07/24/2067231/0/en/Aleafia-Health-Approved-by-Janssen-Pharmaceuticals-to-Administer-Antidepressant-SPRAVATO.html
Nah hgen , most of hgen management are former jnj execs and lenzilumab is upstream of cydy Leronlimab .
Also venrock is behind humanigen also much easier share structure to swallow 200 mm humanigen vs 600mm cydy
GLTA
When the smoke clears, they will be coming to CytoDyn for their leronlimab treatment for Covid. NO SAEs, proven to save lives in e-IND trials and positive results from P2 and P3 trials in next two weeks. CYDY will be the next rocket stock to shake the market.
They should make a play for HGEN , former JNJ executive at helm would be a great great asset for growth
Why is JNJ not making a play for TMDI? This is obviously assuming they aren't doing things behind the scenes.
JNJ Partner Confirms Discovery of Antibodies Targeting SARS-CoV-2!
VICTORIA, BC, June 29, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), an experienced leader in full-service, therapeutic antibody discovery and development, today announced the identification of numerous lead candidate antibodies with highly-potent neutralizing activity in vitro, which are being manufactured for further testing and possible inclusion in the Company's PolyTopeTM mAb Therapy to combat the COVID-19 pandemic.
On March 12th, 2020, ImmunoPrecise announced several preclinical programs currently being undertaken to assist in the efforts against SARS-CoV-2. Today's announcement updates the Company's progress on the development of a PolyTope™ mAb therapy designed to treat severely ill patients, as well as protect high-risk individuals such as those exposed to the virus, front-line workers, the elderly, and the immunocompromised.
ImmunoPrecise deployed several proprietary discovery platforms that leveraged the immune systems of humans, llama, rabbits and Ligand Pharmaceutical's (NASDAQ:LGND) OmniAbÒ genetically engineered rats producing human antibodies. The neutralizing antibodies announced today are the result of functional screenings from the top 300 lead antibodies analyzed from the human and llama campaigns. The Company has stated that functional analysis of the remaining 1,300 lead antibodies from the rabbit and OmniAbÒ rat campaigns were performed independently, and they anticipate the release of the preliminary functional data screens from these additional programs in the near future.
"Arriving at this critical point in our preliminary research with many lead, functional therapeutic candidates is indicative of the broad scientific scope of IPA's anti-COVID-19 programs," stated Dr. Jennifer Bath, CEO and President of IPA. "An effective cocktail therapy for COVID-19, targeting multiple epitopes on the virus, could prove fundamental in combating this pandemic in an effective and enduring way."
The Company's scientific approach has led to a diverse set of lead antibody candidates, and thus far has generated many potently neutralizing antibodies to multiple epitopes, supporting the Company's aim of generating a therapeutic that retains efficacy, even as SARS-CoV-2 continues to evolve. To further support the Company's robust scientific approach, IPA is preparing to test these lead antibodies against additional, documented, mutated strains of the virus.
The Company anticipates pre-clinical studies will begin summer 2020.
Jennifer Bath, Ph.D., Chief Executive Officer of ImmunoPrecise, has reviewed and approved the scientific disclosure of this news release.
The use of therapeutics for humans in clinical trials will require approval of the applicable government regulation agency, e.g. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain COVID-19 (or SARS-CoV-2) at this time.
Appellate court reduces JNJ’s talcum-powder damages from $4.7B to $2.1B:
https://www.wsj.com/articles/missouri-court-cuts-talc-powder-verdict-against-j-j-11592935876
COVID-19 Supplements: Medical researchers from the Harvard Medical School, University of California-Davis, Virginia Commonwealth University and Institute for Systems Biology, Seattle have discovered that chemical molecules called resolvins which are a type of novel endogenous specialized pro-resolving lipid autacoid mediators (SPMs) could help prevent the cytokine storms caused by the COVID-19 disease.
Above was posted last evening on the Facebook Amarin Investors Page.
GILD is using Vascepa in an oncology indication. Why not with Remdesivir?
*******************
Resolvin - Wikipediaen.wikipedia.org › wiki › Resolvin
Resolvins are specialized pro-resolving mediators (SPMs) derived from omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as well as docosapentaenoic acid (DPA) and clupanodonic acid.
$JNJ over to IBIO https://www.otcmarkets.com/stock/IBIO/news/story?e&id=1585740
“If our own proprietary SARS-CoV-2 Virus-Like Particle (“VLP”) program, IBIO-200, results in an approved vaccine, we estimate that we could make about 500 million doses of high-quality product annually at our Texas facility, depending upon the potency we see in the clinic,” said Tom Isett, Co-Chairman & CEO of $iBio
Looking for an entry here. There should be a huge push coming into Robotics, creating an extreme amount of growth if my sources are right.
JnJ and Pctl what a team they would make. Pctl kills 99.9999% VIRUSES,SUPERBUGS and FUNGI. PCTL OH YEAH WE CAN HELP! A ONCE IN A LIFETIME STOCK!
41% of the patients studied who were hospitalized with coronavirus–infected pneumonia are suspected to have gotten the illness through hospital-related transmissions!!!PCTL Specialty. Twitter@PCTL2020 web pcthealthcorp.com
Followers
|
75
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1051
|
Created
|
12/26/04
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |